S&P Biotech SPDR (XBI)
$79.44 2.18 (2.67%)
20:00 EDT XBI Stock Quote Delayed 15 Minutes
Previous Close $79.44
Market Cap 4.29B
PE Ratio -
Volume (Avg. Vol.) 6.03M
Day's Range 79.05 - 82.44
52-Week Range 64.38 - 100.70
Dividend & Yield 0.23 (0.28%)
XBI Stock Predictions, Articles, and S&P Biotech SPDR News
- From InvestorPlace
- From the Web
The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.
Memory stocks like Micron and semiconductor stocks like AMD were on the move in the Nasdaq today. Intel and Cisco weren't so lucky though.
This morning I am recommending a bearish trade on the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).
Biotech ETFs lagged in 2018, but that doesn't mean there aren't healthcare funds to consider for 2019.
As the Best ETFs contest enters its final quarter, there are a few contenders that could reasonably take the trophy for 2018.
As our Best ETFs for 2018 contest crosses into the second half of the year, a few contestants are really making standout gains, but others are making strong moves.
The biotech sector peaked in 2015. While it bounced back from lows, biotech ETFs give investors exposure to the sector as it recovers.
While some of the contenders have been gravitating toward the top or bottom, it's still very much anyone's game in the Best ETFs for 2018 contest.
On Friday, volatility went up while the stocks mostly went down. Looking to cash in on the movement? Try these options for XBI, XLE and EEM.
XBI can profit from full drug pipelines, an improving regulatory climate, high short interest and strengthening technicals.
Biotech stocks are scary when they are falling. Sell downside risk into BIIB stock support with confidence for a chance at free profits.
For a while GILD stock was a hideous knife to catch. But now that it reestablished its bottom, I can safely make money in Gilead.
Pharma stocks like Allergan scare most investors out of trading them when they fall. Sell AGN puts with a big buffer for easy profits.
Biotechnology investors have turned the equal-weight SPDR S&P Biotech ETF (XBI) into one of the largest sector plays. Is it right for you?
The biotech trade is always a momentum bet, and currently Wall Street is betting it will go up. I can use this play in XBI for free income.
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!